Altogether, this indicates that while there is a similar gain of methylation at IC1, the loss of methylation in DMR2 and DMR0 correlates with higher INS-IGF2 levels, potentially contributing to chemotherapy resistance and tumor relapse (Fig. 5c). The gene discussed is IGF2; the disease is neoplasm.